Recombinant Human EVI2B protein (rFc Tag)
种属
Human
纯度
>90 %, SDS-PAGE
标签
rFc Tag
生物活性
未测试
验证数据展示
产品信息
纯度 | >90 %, SDS-PAGE |
内毒素 | <0.1 EU/μg protein, LAL method |
生物活性 |
Not tested |
来源 | HEK293-derived Human EVI2B protein Lys22-Ser202 (Accession# P34910-1) with a rabbit IgG Fc tag at the C-terminus. |
基因ID | 2124 |
蛋白编号 | P34910-1 |
预测分子量 | 45.7 kDa |
SDS-PAGE | 55-90 kDa, reducing (R) conditions |
组分 | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
复溶 | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
储存条件 |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
运输条件 | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
背景信息
Ecotropic viral integration site 2B (EVI2B), also known as CD361, was first reported to be a common viral integration site in retrovirally-induced murine leukemia. Zjablovskaja et al. showed EVI2B was necessary for granulocytic differentiation and functionality of hematopoietic progenitors.
参考文献:
1. Cawthon R.M., et al. Genomics. 1991;9:446–460. 2. Buchberg A.M., et al. Mol. Cell Biol. 1990;10:4658–4666. 3. Zjablovskaja P., et al. Cell Death Differ. 2017;24:705–716.